Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: Analysis of national insurance claims

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 671-682

  Wang, Bih Ru ^a,b   Chang, Yuh Lih ^a,b   Chen, Tzeng Ji ^a,b   Chiu, Jen Hwey ^a,b   Wu, Jing Chong ^c   Wu, Min Shan ^a   Chou, Chia Lin ^a   Chou, Yueh Ching ^a,b,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Complementary and alternative medicine; Drug utilization patterns; Pharmacoep idemiology

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ETOPOSIDE; EXEMESTANE; FLUOROURACIL; FLUOXYMESTERONE; GEMCITABINE; GOSERELIN; LETROZOLE; LEUPRORELIN; MEGESTROL; METHOTREXATE; MITOXANTRONE; NAVELBINE; PACLITAXEL; PARACETAMOL; TAMOXIFEN; TOREMIFENE; TRASTUZUMAB; VINBLASTINE;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOMYOPATHY; CARDIOTOXICITY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH INSURANCE; HEART FAILURE; HERBAL MEDICINE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH INSURANCE; PRESCRIPTION; REGISTER; TAIWAN; TERMINAL DISEASE; VERY ELDERLY; WESTERN MEDICINE;

EID: 84900406397     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S61280     Document Type: Article

References (60)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Bureau of Health Promotion, Department of Health. Cancer registry annual report, 2010, Taiwan. 2013. Available from: http://www.hpa.gov.tw/BHPNet/Portal/File/StatisticsFile/201305061037065219/99%E5%B9%B4%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%A0%B1%E5%91%8A.pdf. Accessed April 29, 2014.
3. Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-1792.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.
5. Howell A, Cuzick J, Baum M, et al; ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60-62.
6. Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med. 2010;362(22):2053-2065.
7. Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med. 2007;357(1):39-51.
8. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344(26):1997-2008.
9. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med. 2008;14(8):1049-1055.
10. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs. 2010;14(4):E45-E55.
11. Chen FP, Chen TJ, Kung YY, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7:26.
12. Chung V, Wong E, Woo J, Lo SV, Griffiths S. Use of traditional Chinese medicine in the Hong Kong special administrative region of China. J Altern Complement Med. 2007;13(3):361-367.
13. Hesketh T, Zhu WX. Health in China. Traditional Chinese medicine: one country, two systems. BMJ. 1997;315(7100):115-117.
14. Lai JN, Wu CT, Wang JD. Prescription pattern of Chinese herbal products for breast cancer in Taiwan: a population-based study. Evid Based Complement Alternat Med. 2012;2012:891893.
15. Lin YH, Chiu JH. Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan. Complement Ther Med. 2011;19(3):137-143.
16. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res. 2008;8:170.
17. National Health Insurance Research Database [database on the Internet]. Taipei, Taiwan: National Health Research Institutes; 2003. Available from: http://nhird.nhri.org.tw/. Accessed January 5, 2012.
18. National Health Insurance Administartion Ministry of Health and Welfare [webpage on the Internet]. [Bureau of National Health Insurance: List of reimbursed drugs]. Available from: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id=879&webdata_id=873. Accessed January 5, 2012. Chinese.
19. Department of Chinese Medicine and Pharmacy. [Database of registered Chinese herbal medicines-current and withdrawn]. Available from: http://www.mohw.gov.tw/cht/DOCMAP/DM1.aspx?f_list_no=499. Accessed April 23, 2014. Chinese.
20. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo, Norway: World Health Organization; 2012. Available from: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf. Accessed January 5, 2012.
21. Lin YH, Chen KK, Chiu JH. Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan. Evid Based Complement Alternat Med. 2012;2012:147015.
22. Lin YH, Chiu JH. Use of Chinese Medicine among patients with liver cancer in Taiwan. J Altern Complement Med. 2010;16(5):527-528.
23. Chen HY, Lin YH, Wu JC, et al. Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database. J Ethnopharmacol. 2011;137(3):1261-1266.
24. Yang YH, Chen PC, Wang JD, Lee CH, Lai JN. Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan. Climacteric. 2009;12(6):541-547.
25. Scheid V, Ward T, Cha WS, Watanabe K, Liao X. The treatment of menopausal symptoms by traditional East Asian medicines: review and perspectives. Maturitas. 2010;66(2):111-130.
26. Scheid V, Ward T, Tuffrey V. Comparing TCM textbook descriptions of menopausal syndrome with the lived experience of London women at midlife and the implications for Chinese medicine research. Maturitas. 2010;66(4):408-416.
27. Chen LC, Tsao YT, Yen KY, Chen YF, Chou MH, Lin MF. A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms. Maturitas. 2003;44(1):55-62.
28. Lai JN, Hwang JS, Chen HJ, Wang JD. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women. J Altern Complement Med. 2005;11(6):1075-1084.
29. Chen FP, Jong MS, Chen YC, et al. Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002. Evid Based Complement Alternat Med. 2011;2011:236341.
30. Yeh CH, Arnold CK, Chen YH, Lai JN. Suan zao ren tang as an original treatment for sleep difficulty in climacteric women: a prospective clinical observation. Evid Based Complement Alternat Med. 2011;2011:673813.
31. Yeung WF, Chung KF, Poon MM, et al. Prescription of Chinese herbal medicine and selection of acupoints in pattern-based traditional Chinese medicine treatment for insomnia: a systematic review. Evid Based Complement Alternat Med. 2012;2012:902578.
32. Peng WH, Hsieh MT, Lee YS, Lin YC, Liao J. Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol. 2000;72(3):435-441.
33. Jiang JG, Huang XJ, Chen J. Separation and purification of saponins from Semen Ziziphus jujuba and their sedative and hypnotic effects. J Pharm Pharmacol. 2007;59(8):1175-1180.
34. Ye R, Yuan ZZ, Dai CX. [Intervention of tianwang buxin decoction combined with dormancy hygiene education for treatment of sub-healthy insomnia patients of yin deficiency fire excess syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011;31(5):618-621. Chinese [with English abstract].
35. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 2003;348(24):2431-2442.
36. Felson DT, Cummings SR. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum. 2005;52(9):2594-2598.
37. Mao JJ, Chung A, Benton A, et al. Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf. 2013;22(3):256-262.
38. Liu M, Xiao GG, Rong P, et al. Therapeutic effects of radix dipsaci, pyrola herb, and Cynomorium songaricum on bone metabolism of ovariectomized rats. BMC Complement Altern Med. 2012;12:67.
39. Chen CW, Sun J, Li YM, Shen PA, Chen YQ. Action mechanisms of du-huo-ji-sheng-tang on cartilage degradation in a rabbit model of osteoarthritis. Evid Based Complement Alternat Med. 2011;2011:571479.
40. Lai JN, Chen HJ, Chen CC, Lin JH, Hwang JS, Wang JD. Duhuo jisheng tang for treating osteoarthritis of the knee: a prospective clinical observation. Chin Med. 2007;2:4.
41. Shih WT, Yang YH, Chen PC. Prescription patterns of Chinese herbal products for osteoporosis in Taiwan: a population-based study. Evid Based Complement Alternat Med. 2012;2012:752837.
42. Hinoshita F, Ogura Y, Suzuki Y, et al. Effect of orally administered shao-yao-gan-cao-tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: a preliminary study. Am J Chin Med. 2003;31(3):445-453.
43. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339(13):900-905.
44. Perez EA, Rodeheffer R. Clinical cardiac tolerability of trastuzumab. J Clin Oncol. 2004;22(2):322-329.
45. Zheng H, Chen Y, Chen J, Kwong J, Xiong W. Shengmai (a traditional Chinese herbal medicine) for heart failure [review]. Cochrane Database Syst Rev. 2011;2:CD005052.
46. Chen WG, Ba ZM. Prof. ZHANG Yi's experience in treating severe arrhythmia. J Tradit Chin Med. 2010;30(1):47-50.
47. Xiao Y, Liu YY, Yu KQ, Ouyang MZ, Luo R, Zhao XS. Chinese herbal medicine liu jun zi tang and xiang sha liu jun zi tang for functional dyspepsia: meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2012;2012:936459.
48. Xu H, Zhang WX. Modern Applications of Modified Ban Xia Xie Xin Tang and Their Development. Australian Journal of Acupuncture and Chinese Medicine. 2008;3(1):25-30.
49. Zhao L, Zhang S, Wang Z, et al. Efficacy of modified ban xia xie xin decoction on functional dyspepsia of cold and heat in complexity syndrome: a randomized controlled trial. Evid Based Complement Alternat Med. 2013;2013:812143.
50. Yamazaki T, Matsushita Y, Kawashima K, Someya M, Nakajima Y, Kurashige T. Evaluation of the pharmacological activity of extracts from amomi semen on the gastrointestinal tracts. J Ethnopharmacol. 2000;71(1-2):331-335.
51. Bose S, Kim H. Evaluation of In Vitro Anti-Inflammatory Activities and Protective Effect of Fermented Preparations of Rhizoma Atractylodis Macrocephalae on Intestinal Barrier Function against Lipopolysaccharide Insult. Evid Based Complement Alternat Med. 2013;2013:363076.
52. Kim SH, Ahn BZ, Ryu SY. Antitumour effects of ursolic acid isolated from Oldenlandia diffusa. Phytother Res. 1998;12(8):553-556.
53. Lu B, Xu L, Yu L, Zhang L. Extract of radix curcumae prevents gastric cancer in rats. Digestion. 2008;77(2):87-91.
54. Lu B, Yu L, Xu L, Chen H, Zhang L, Zeng Y. The effects of radix curcumae extract on expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats fed with MNNG. Curr Pharm Biotechnol. 2010;11(3):313-317.
55. Kumagai T, Müller CI, Desmond JC, Imai Y, Heber D, Koeffler HP. Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leuk Res. 2007;31(4):523-530.
56. Kurashige S, Akuzawa Y, Endo F. Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine. Cancer Invest. 1999;17(1):30-35.
57. Chang CJ, Chiu JH, Wu CW, Lui WY. Herb-related aneuploidy in breast fibroadenoma. BMJ Case Rep. Epub 2009 May 12.
58. Chang CJ, Chiu JH, Tseng LM, et al. Si-Wu-Tang and its constituents promote mammary duct cell proliferation by up-regulation of HER-2 signaling. Menopause. 2006;13(6):967-976.
59. Chang CJ, Chiu JH, Tseng LM, et al. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur J Clin Invest. 2006;36(8):588-596.
60. Chen JL, Wang JY, Tsai YF, et al. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab. Menopause. 2013;20(6):646-654.